Completely updated and revised, the 32nd edition of this best-selling reference “Nelsons Pediatric Antimicrobial Therapy 2026“from the American Academy of Pediatrics delivers the latest evidence-based recommendations for the treatment of infectious diseases in children. Each disease is accompanied by expert commentary, helping clinicians choose the best antimicrobial options based on current research and clinical experience. It is designed as a comprehensive resource that includes detailed descriptions of all antimicrobial agents available today, complete with their dosing regimens.
Key Features
-
Fungal Pathogen Updates: Features an updated Chapter 5 covering candidiasis therapy for systemic infections, and Chapter 6 dosage updates for posaconazole and isavuconazole.
-
Prophylaxis Guidelines: Chapter 15 includes new information on postexposure prophylaxis for tuberculosis and neonatal herpes simplex virus, as well as prophylaxis for recurrent mucocutaneous herpes simplex virus.
-
Surgical Prophylaxis Updates: Includes updated intraoperative re-dosing intervals for prolonged surgeries and the addition of piperacillin/tazobactam therapy for complicated appendicitis or other ruptured colorectal viscus.
-
New Antimicrobial Agents: Chapter 18 now includes updated systemic antimicrobials with dosage forms for Ceftobiprole medocaril sodium (Zevtera), Geptotidacin (Blujepa), Minocycline ER (Emrosi), and Paromomycin (Humatin).
-
Expert Authorship: Edited by Editor in Chief Debra L. Palazzi, MD, MEd, alongside past editor John S. Bradley, MD, and a distinguished team of contributing experts.
Reviews
There are no reviews yet.